NVO Q2 2017 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

Q2 2017 Earnings

Reported June 29, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2017	Q1 2017	Q2 2016	QoQ Change	YoY Change
Revenue	$4.5B	$4.5B	$4.3B	0.7%	4.3%
Op. Income	$2.1B	$2.1B	$2.0B	-0.8%	7.1%
Gross Margin	84.6%	85.1%	85.3%	-0.5pp	-0.7pp
Net Margin	34.7%	35.7%	36.3%	-0.9pp	-1.6pp
EPS (Diluted)	$0.31	$0.32	$0.31	-1.0%	2.6%
Free Cash Flow	$1.3B	$1.6B	$2.0B	-19.0%	-34.0%

Revenue Flow

Item	Amount
REVENUE	$4.5B
Cost of Revenue	$691M
GROSS PROFIT	$3.8B
R&D Expenses	$535M
Selling & Marketing	$1.1B
General & Administrative	$134M
SG&A Expenses	$1.2B
Other Expenses	-$30M
Operating Expenses	$1.7B
Cost & Expenses	$2.4B
OPERATING INCOME	$2.1B
Interest Income	$66M
Interest Expense	$182M
Other Income/Expenses	-$116M
INCOME BEFORE TAX	$2.0B
Income Tax Expense	$422M
Net Income from Continuing Ops	$1.6B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.6B
D&A	$135M
EBIT	$2.2B
EBITDA	$2.3B
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$4.5B
Cost of Revenue	$691M
GROSS PROFIT	$3.8B
R&D Expenses	$535M
Selling & Marketing	$1.1B
General & Administrative	$134M
SG&A Expenses	$1.2B
Other Expenses	-$30M
Operating Expenses	$1.7B
Cost & Expenses	$2.4B
OPERATING INCOME	$2.1B
Interest Income	$66M
Interest Expense	$182M
Other Income/Expenses	-$116M
INCOME BEFORE TAX	$2.0B
Income Tax Expense	$422M
Net Income from Continuing Ops	$1.6B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.6B
D&A	$135M
EBIT	$2.2B
EBITDA	$2.3B
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$1.6B
Depreciation & Amortization	$135M
Stock-Based Compensation	$0
Deferred Income Tax	$422M
Other Non-Cash Items	-$83M
Change in Working Capital	-$250M
OPERATING CASH FLOW	$1.6B
Capital Expenditure	-$267M
Acquisitions (Net)	$23M
Purchases of Investments	-$6M
Sales/Maturities of Investments	$158M
Other Investing Activities	-$22M
NET CASH FROM INVESTING	-$114M
Net Debt Issuance	$0
Common Stock Repurchased	-$589M
Common Dividends Paid	$0
Other Financing Activities	-$308M
NET CASH FROM FINANCING	-$897M
FREE CASH FLOW	$1.3B
Net Change in Cash	$547M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.3B
Short-Term Investments	$470.0K
Net Receivables	$3.3B
Inventory	$2.4B
Other Current Assets	$822M
TOTAL CURRENT ASSETS	$9.2B
PP&E (Net)	$5.0B
Goodwill	$0
Intangible Assets	$415M
Long-Term Investments	$314M
Tax Assets	$363M
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$6.1B
TOTAL ASSETS	$15.3B
Account Payables	$667M
Short-Term Debt	$264M
Deferred Revenue	$3.7B
Other Current Liabilities	$2.2B
TOTAL CURRENT LIABILITIES	$6.9B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$89M
Other Non-Current Liabilities	$783M
TOTAL NON-CURRENT LIABILITIES	$872M
TOTAL LIABILITIES	$7.7B
Common Stock	$78M
Additional Paid-In Capital	$0
Retained Earnings	$7.4B
Treasury Stock	-$783.3K
Accum. Other Comp. Income	$145M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$7.6B
Minority Interest	$0
TOTAL EQUITY	$7.6B
TOTAL LIABILITIES & EQUITY	$15.3B
Total Debt	$264M
Net Debt	-$3.1B